Enzychem Lifesciences Decides on a 316.4 Billion KRW Capital Increase
[Asia Economy Reporter Minji Lee] Engchem Life Sciences announced on the 17th that it has decided on a paid-in capital increase worth 316.4 billion KRW through a rights offering to shareholders followed by a general public offering of unsubscribed shares.
Hot Picks Today
!["Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2025050713592847164_1746593968.jpg)
"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Hong Joonpyo: "Jung Wonoh Incident Reminds Me of the 'Pig Aphrodisiac Case'... A Policy Contest Is Needed"
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- Jay Y. Lee Bows His Head: "I Will Face the Harsh Storm"...Apologizes for Samsung Labor-Management Conflict
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
